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Abstract
The presence of persister cells has been proposed as a factor in biofilm resilience. In the present study we investigated
whether persister cells are present in Burkholderia cepacia complex (Bcc) biofilms, what the molecular basis of antimicrobial
tolerance in Bcc persisters is, and how persisters can be eradicated from Bcc biofilms. After treatment of Bcc biofilms with
high concentrations of various antibiotics often a small subpopulation survived. To investigate the molecular mechanism of
tolerance in this subpopulation, Burkholderia cenocepacia biofilms were treated with 1024 mg/ml of tobramycin. Using ROS-
specific staining and flow cytometry, we showed that tobramycin increased ROS production in treated sessile cells.
However, approximately 0.1% of all sessile cells survived the treatment. A transcriptome analysis showed that several genes
from the tricarboxylic acid cycle and genes involved in the electron transport chain were downregulated. In contrast, genes
from the glyoxylate shunt were upregulated. These data indicate that protection against ROS is important for the survival of
persisters. To confirm this, we determined the number of persisters in biofilms formed by catalase mutants. The persister
fraction in DkatA and DkatB biofilms was significantly reduced, confirming the role of ROS detoxification in persister survival.
Pretreatment of B. cenocepacia biofilms with itaconate, an inhibitor of isocitrate lyase (ICL), the first enzyme in the glyoxylate
shunt, reduced the persister fraction approx. 10-fold when the biofilms were subsequently treated with tobramycin. In
conclusion, most Bcc biofilms contain a significant fraction of persisters that survive treatment with high doses of
tobramycin. The surviving persister cells downregulate the TCA cycle to avoid production of ROS and at the same time
activate an alternative pathway, the glyoxylate shunt. This pathway may present a novel target for combination therapy.
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Introduction
Burkholderia cenocepacia is a member of the Burkholderia cepacia
complex (Bcc), a group of 17 closely related and phenotypically
similar species [1]. These bacteria are opportunistic pathogens that
can cause severe lung infections in immunocompromised people,
including cystic fibrosis (CF) patients [2]. The prevalence and
outcome of infections appear to be species dependent and
infections with Burkholderia multivorans and B. cenocepacia are
associated with high rates of transmission and high mortality [3].
B. cenocepacia J2315 belongs to the highly transmissible ET12
lineage which has infected many CF patients in Canada, the UK
and various European countries [4]. Unfortunately, Bcc organisms
are difficult to eradicate because of their innate resistance to a wide
range of antibiotics and their capacity to form biofilms [5].
Mechanisms of resistance include changes in lipopolysaccharide
structure, the presence of several multidrug efflux pumps,
inducible chromosomal b-lactamases and altered penicillin-bind-
ing proteins [6]. In addition, biofilm-associated cells are often
more tolerant to antimicrobials than planktonic cells [7] due to
reduced drug penetration in the biofilm, the lower growth rate of
sessile cells and/or the expression of specific resistance genes [8,9].
Even when patients are treated with high doses of antibiotics
known to be effective against Bcc species in vitro, it is often
impossible to clear the infection [10].
Persister cells, cells that have entered a dormant multidrug-
tolerant state, are thought to be involved in the recalcitrance of
biofilm related infections [11]. These persisters are not mutants
but phenotypic variants of the wild type [11]. Upon treatment of a
biofilm with high doses of an antibiotic most of the bacteria are
killed, but some of them neither grow nor die. After removal of the
antibiotic, these surviving cells will start to grow and will give rise
to a new infection. The resulting biofilm will again only contain a
very small fraction of persister cells [12]. The mechanisms leading
to persistence are not well understood. Screening knockout mutant
libraries has not led to the identification of mutants completely
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lacking persister cell formation, suggesting that dormancy mech-
anisms are redundant [11]. Currently, it is assumed that toxin/
antitoxin modules are involved in persister formation [12]. Toxins
are proteins that inhibit important cellular functions such as
translation or replication. This condition can be reversed by the
expression of the corresponding antitoxin which can form an
inactive complex with the toxin. By causing a reversible dormant
state, toxins protect bacteria against antibiotics which require
active targets in order to be effective [11]. The phenomenon of
persister formation in exponentially growing planktonic cultures
has been demonstrated for several micro-organisms (including
Escherichia coli, Pseudomonas aeruginosa, Staphylococcus aureus and
Mycobacterium tuberculosis) [11], but has so far not been investigated
in the Bcc.
Recently, Kohanski et al. demonstrated that the production of
reactive oxygen species (ROS) contributes to the antimicrobial
activity of bactericidal antibiotics. The primary drug-target
interactions stimulate the oxidation of NADH via the electron
transport chain, which itself is dependent on the tricarboxylic acid
cycle (TCA). A hyperactivation of the electron transport chain
results in increased superoxide formation, leading to damage to
iron-sulfur clusters in proteins with the release of ferrous iron. This
ferrous iron can be oxidised in the Fenton reaction with the
production of hydroxyl radicals capable of damaging proteins,
DNA and lipids and ultimately leading to cell death [13].
The glyoxylate cycle is an anaplerotic pathway of the TCA
cycle, which bypasses the decarboxylation steps in which NADH is
produced. This pathway allows microorganisms to utilize simple
carbon compounds as a carbon source [14]. The glyoxylate cycle
is absent in humans, making it an interesting drug target [14]. For
example, Van Schaik et al [15] found that inhibition of isocitrate
lyase (ICL, the first enzyme of this shunt), by itaconate during
experimental chronic Burkholderia pseudomallei lung infections forces
the infection into an acute state, which can then be treated with
antibiotics.
In the present study we wanted to investigate whether persister
cells are present in Bcc biofilms, what the molecular basis of
antimicrobial tolerance in Bcc persisters is, and how persisters can
be eradicated from Bcc biofilms.
Materials and Methods
Strains and Culture Conditions
The strains used in the present study are shown in Tables 1 and 2
[16,17]. All strains were cultured at 37uC on Luria-Bertani agar
(LBA, Oxoid, Hampshire, UK) or on Mueller Hinton agar (MHA,
Oxoid). Overnight cultures were diluted in Luria-Bertani broth
(LBB, Oxoid) and incubated aerobically at 37uC. The succinate
dehydrogenase antisense overexpression mutants were grown on
LBA supplemented with 800 mg/ml trimethoprim (Tp) (Ludeco,
Brussels, Belgium) or in LBB supplemented with 800 mg/ml Tp and
0.2% rhamnose (Sigma Aldrich, Bornem, Belgium).
Minimal Inhibitory Concentration (MIC)
MICs were determined in duplicate according to the EUCAST
broth microdilution protocol using flat-bottom 96-well microtiter
plates (TPP, Trasadingen, Switzerland) [18]. Tobramycin and
ciprofloxacin (Sigma Aldrich) concentrations tested ranged from
0.25 to 1024 mg/ml and from 0.25 to 128 mg/ml, respectively.
Itaconate and 3-nitropropionate (3-NP) (Sigma Aldrich) concen-
trations ranged from 0.20 to 100 mM. 2-Thenoyltrifluoroacetone
(Sigma Aldrich) concentrations ranged from 5 to 625 nM. The
MIC was defined as the lowest concentration for which no
significant difference in optical density (l=590 nm) was observed
between the inoculated and blank wells after 24 h incubation.
Differences in absorbance were considered significant when the
95%-confidence interval (calculated using Microsoft Excel) did not
contain zero. All MIC determinations were performed in duplicate
and replicates never differed more than two fold. When a two fold
Table 1. Strains used in the present study.
Strain LMG number Strain information Source (reference)
B. cenocepacia J2315 LMG 16656 CF patient, UK, ET12 strain BCCM/LMG Bacteria Collection
B. cenocepacia K56-2 LMG 18863 CF patient, Canada BCCM/LMG Bacteria Collection
B. cenocepacia C5424 LMG 18827 CF patient, Canada Miguel Valvano [16]
B. cenocepacia MDL1 C5424 DkatA mutant strain Miguel Valvano [16]
B. cenocepacia MDL2 C5424 DkatB mutant strain Miguel Valvano [16]
B. cenocepacia D2 DBCAL2118DBCAM1588 This study
B. cenocepacia SDH7 Overexpression of BCAM0967 This study
B. cenocepacia SDH8 Overexpression of BCAM0968 This study
B. ambifaria AMMD LMG 19182 Pea rhizosphere, USA BCCM/LMG Bacteria Collection
B. cenocepacia HI2424 LMG 24507 Soil, USA, PHDC strain John LiPuma [17]
B. lata ATCC 17769 LMG 6992 Soil, Trinidad and Tobago BCCM/LMG Bacteria Collection
B. multivorans ATCC 17616 LMG 17588 Soil, USA BCCM/LMG Bacteria Collection
B. vietnamiensis ATCC 53617 LMG 22486 Wastewater, USA BCCM/LMG Bacteria Collection
B. dolosa R-5670 LMG 18943 CF patient, US BCCM/LMG Bacteria Collection
B. contaminans CCUG 34411 LMG 16227 CF patient, Sweden BCCM/LMG Bacteria Collection
B. ubonensis NCTC 13147 LMG 20358 Surface soil, Thailand BCCM/LMG Bacteria Collection
B. cepacia ATCC 25416 LMG 1222 Allium cepa, US BCCM/LMG Bacteria Collection
B. pyrrocinia ATCC 15958 LMG 14191 Soil, US BCCM/LMG Bacteria Collection
doi:10.1371/journal.pone.0058943.t001
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difference was observed between replicates, the lowest concentra-
tion was recorded as the MIC.
Quantification of Persister Cells in Biofilms and Planktonic
Cultures
To determine the number of surviving cells, 24 h old biofilms or
planktonic cultures were exposed to tobramycin, an aminoglyco-
side antibiotic, or ciprofloxacin, a fluoroquinolone, in concentra-
tions ranging from 0.5 to 646 the MIC for 24 h. Biofilms were
grown in the wells of a round-bottom 96-well microtiter plate
(TPP), as described previously [19]. After 24 h of growth, the
supernatant was removed and 120 ml of an antibiotic solution in
physiological saline (PS) or 120 ml PS ( = control) was added and
the plates were further incubated at 37uC. Twelve wells were used
for each condition. After 24 h of treatment, cells were harvested by
vortexing and sonication (265 min) (Branson 3510, Branson
Ultrasonics Corp, Danbury, CT) and quantified by plating on LB
(n $2 for all experiments). For the planktonic experiments an
overnight culture was diluted to an optical density of 0.1
(approximately 108 cells/ml). After an additional 24 h growth in
a shaking warm water bath, cell suspensions with an optical
density of 1 (approximately 109 cells/ml) were transferred to
falcon tubes and centrifuged for 9 min at 5000 rpm. Cells were
resuspended in an antibiotic solution in PS, or in PS and further
incubated at 37uC. After 24 h of treatment the tubes were
centrifuged, resuspended in PS and quantified by plating on LB
(n $2 for all experiments).
RNA Extraction and Microarray Analysis
Biofilms were grown as described above and exposed to an
antibiotic (concentration of 46MIC) or a 0.9% NaCl solution
(untreated controls) for 24 h. Treated and untreated B. cenocepacia
J2315 sessile cells were harvested by vortexing (5 min) and
sonication (5 min) and transferred to sterile tubes. RNA was
extracted immediately following harvesting of the cells, using the
Ambion RiboPure Bacteria Kit (Ambion, Austin, TX) according
to the manufacturer’s instructions and the procedure included a
DNase I treatment for 1 h at 37uC. After extraction, RNA of both
treated and untreated samples was concentrated using Microcon
YM-50 filter devices (Milipore, Billerica, MA) and linearly
Table 2. The MIC and fraction of persisters for early and late Bcc clonal isolates obtained from infected CF patients.
Species Strain
Time interval
(years) MIC
Average % persisters
(n =3) SD
Clonal isolates from Canada
B. multivorans C8298 8 Early 64 0.1551 0.2352
D2156 Late 64 0.0068 0.0076
B. multivorans C8814 5 Early 32 0.3411 0.3080
D0999 Late 128 0.0012 0.0008
B. multivorans C6396 9 Early 64 0.0031 0.0004
D0913 Late 128 0.0005 0.0003
B. cenocepacia C4053 6 Early 128 0.0004 0.0004
C6121 Late 64 0.0019 0.0009
B. cenocepacia C3921 10 Early 1024 0.0249 0.0270
C9343 Late 1024 0.0051 0.0044
B. cenocepacia C6483 4 Early 256 0.0019 0.0031
C8474 Late 256 0.0214 0.0363
B. cenocepacia C4629 7 Early 128 0.0226 0.0326
C8482 Late 128 0.0036 0.0007
B. cenocepacia C5876 8 Early 128 0.0020 0.0004
D0465 Late 256 0.0000 0.0001
B. cenocepacia C5424 3 Early 256 0.0527 0.0753
C7376 Late 128 0.0114 0.0152
Clonal isolates from the US
B. cenocepacia AU0326 11 Early 256 0.0066 0.0095
AU18962 Late 512 0.0276 0.0441
B. cenocepacia AU0734 13 Early 256 0.0010 0.0007
AU21801 Late 256 0.0001 0.0001
B. vietnamiensis AU0808 12 Early 16 0.0019 0.0025
AU21645 Late 8 0.0092 0.0116
B. dolosa AU3503 10 Early 32 0.0040 0.0044
AU21993 Late 32 0.0821 0.0702
B. dolosa AU0265 14 Early 128 0.9246 0.7618
AU21961 Late 128 0.1230 0.1847
doi:10.1371/journal.pone.0058943.t002
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amplified using the MessageAmp II-Bacteria Kit (Ambion) prior to
the microarray analysis. The method was first optimised with the
use of standard Escherichia coli RNA. Assessment of RNA yield and
quality, cDNA synthesis and the hybridization and washing of the
custom made 4644K arrays (Agilent, Santa Clara, CA) was
performed as described previously [20]. The gene expression
analysis was performed using GeneSpring GX 7.3 (Agilent) and
data were normalized using the procedure recommended for two-
colour Agilent microarrays. Only features dedicated to B.
cenocepacia J2315 that were labelled ‘‘present’’ or ‘‘marginal’’ were
included in the analysis. After this initial filtering, a student’s T-test
analysis was performed (p,0.05). The experimental protocols and
the raw microarray data can be found in ArrayExpress under the
accession number E-MEXP-3532.
Quantitative RT-PCR
In order to validate the microarray results, the expression of 11
selected genes was examined using RT-qPCR. Biofilms were
treated and RNA was extracted as described above. cDNA was
synthesized using the iScript cDNA Synthesis Kit (Bio-Rad,
Hercules, CA). Forward and reverse primers were developed using
tools available on the NCBI website and they were compared with
the B. cenocepacia J2315 genome sequence using BLAST to
determine their specificity (Table 3). The primer concentration
used was 600 nM (300 nM for BCAM1588). All qPCR experi-
ments were performed on a Bio-Rad CFX96 Real-Time System
C1000 Thermal Cycler as described previously [20]. Each sample
was spotted in duplicate and control samples without added cDNA
were included in each experiment. The initial 3 min denaturation
step at 95uC was followed by 40 amplification cycles, consisting of
15 s at 95uC and 60 s at 60uC. A melting curve analysis was
included at the end of each run. To allow accurate normalization
of our data, we also included three reference genes (BCAL2694,
BCAS0175, BCAM2784) for which we confirmed expression
stability using GeNorm [21] prior to the actual analyses (Figure
S1).
Flow Cytometry
The induction of ROS by tobramycin was confirmed by
staining of treated (46MIC tobramycin, 24 h) and untreated
biofilms with the ROS-specific fluorescent dye 29,79-dichlorodihy-
dro-fluorescein diacetate (DCFHDA, Sigma Aldrich), followed by
quantification of labeled cells by flow cytometry. After 24 h of
treatment, as described above, 22 ml DCFHDA (0.1 mM) was
added to each well. After a 30 min incubation at 37uC in the dark,
the wells were rinsed and 100 ml PS was added. Tobramycin-
treated and untreated sessile cells were harvested by scraping and
then transferred to sterile tubes. The tubes were centrifuged (for
Table 3. Primer sequences.
Gene Annotation FW primer RV primer
Glyoxylate shunt
BCAL2122 Malate synthase GGCCGACCGCTCGAAGATCA CGCCTTGTCGTTCGCTTCCG
BCAL2118 Isocitrate lyase GCACCGTACGCCGACCTGAT GCTTGCCCGGGAACTGCTTG
BCAM1588 Isocitrate lyase TCCTTGCCCGCTGCCTTCAT ATCCCGAACGCGAAGCTGGT
Tricarboxylic acid cycle
BCAM0961 Aconitate hydratase CTCGGCCAGCCGGTGTACTT CAGCGACTTCGTGCCTTCGC
BCAM2701 Aconitate hydratase CGGTGATCCAGGCGCAGGAT CAGGCGCATCCACGATGCAC
BCAM1833 Aconitate hydratase/methylisocitrate dehydratase GCATGCTGACGGTCGCCAAG GGTCGGGCAGGCCTTCGATT
BCAL2735 Isocitrate dehydrogenase CGCTGAAGCCGGAAGCGAAC ACCGCGCTGCCCTTGATCTT
BCAL2736 Isocitrate dehydrogenase ATCAAGGGGCCGCTCACGAC GGCGCAGGCACACGTAGAGA
BCAL1517 Dihydrolipoamide dehydrogenase GAAGTGAGCGGCGAGGGTGA TCGGCACCGAGTCGAACGTC
BCAL0957 Succinyl-CoA synthethase subunit alpha ACGCAGGGCATTACCGGCAA CGCGGCCGTTTGCGTATTCA
BCAM0970 Succinate dehydrogenase iron-sulfur subunit CCTCCAGTCGCCGGAAGAGC CACCAGAAGCTCGGGCACGA
BCAM0965 Malate dehydrogenase CCGGTCGCGTCGATCGAGAA GCGAAGCGGAAGTCCGGGTA
Other genes
BCAM2318 Putative ferredoxin oxidoreductase TGAAGCTGATCGCGCCGGAT GCGCACCGCCTTCATGTACG
Reference genes
BCAL0036 ATP synthase beta chain CAAGACCGTCAACATGATGGA TCGAGTCCTTCATTTCGTGGTA
BCAL0289 Glutamate synthase ATCATCCAGCAGGGTCTGAAGA GCCATTTCCTCGCGATAGAA
BCAL0421 DNA gyrase B subunit GTTCCACTGCATCGCGACTT GGGCTTCGTCGAATTCATCA
BCAL1459 Calcineurin-like phosphoesterase ATCCCTTGAAATCGAGCATCA TACGCTCGACAACGTGCATTA
BCAL1659 Ribose transport permease ACCGTGTTCGGACGCTATCT CATCAGTGCGAATACGAGAATTTT
BCAL1861 Acetoacetyl-CoA reductase GATCACCTGCTTCGTGACGTT GACGTCGTGTTCCGCAAGAT
BCAL2694 Dehydrogenase CTTGCCGTGATCCTCGAGAT GAGATCAGCGAGGCCGAGTA
BCAM0991 Tryptophane synthase beta chain GCCAACGTCTACCGGATGAA GACCGTGCCGATGATGTAGAA
BCAM2784 Aminotransferase CCCCGTTCTCGCTCTACGT GTGTCGCCGAGGCAGAAAT
BCAS0175 Hydrolase ATGGCCAGTTCGCTCATCA ACGCGATGTCGATACTCGAAT
doi:10.1371/journal.pone.0058943.t003
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6 min, at 9000 rpm), the cells were resuspended and 100 fold
diluted in PS. All solutions were prepared using MQ water
(Millipore, Billerica, MA) and were filter-sterilized before use
(Puradisk FP30; Whatman, Middlesex, UK). Labeled cells were
quantified using a Cyan ADP flow cytometer (Beckman Coulter,
Suarle´e, Belgium) with a 488 nm argon laser and a 530–540 nm
emission filter. Data of at least 50000 cells were collected for each
sample.
Effect of Superoxide Dismutase (SOD), Isocitrate Lyase
(ICL) or Succinate Dehydrogenase (SDH) Inhibition on
Survival of Bcc Persisters
To confirm the importance of protection against ROS for the
survival of persister cells, the number of surviving cells was
quantified in biofilms treated with tobramycin (46MIC, 24 h) in
combination with the SOD inhibitor diethyldithiocarbamate
(0.05 mM) (Sigma Aldrich). To confirm the importance of ICL
for persistence, the number of surviving cells was quantified in
treated (46MIC, 24 h) and untreated biofilms grown in LBB
supplemented with 50 mM itaconate or 10 mM 3-NP, two ICL
inhibitors. These concentrations were below the MIC of these
inhibitors for the strains tested (data not shown). Itaconate and 3-
NP solutions were neutralised with NaOH in LBB and sterilized
by filtration. To evaluate the role of SDH in persistence, the
number of surviving cells was determined in biofilms grown in
LBB supplemented with 250 nM 2-thenoyltrifluoroacetone, a
concentration well below the MIC (data not shown).
Construction of ICL Mutant
The genome of B. cenocepacia J2315 contains two ICL encoding
genes, BCAL2118 and BCAM1588. To confirm their importance,
we constructed a double ICL mutant. All B. cenocepacia mutant
strains were constructed following the protocol described by
Hamad et al., which allows for the creation of unmarked nonpolar
gene deletions [22]. Briefly, this mutagenesis procedure requires
the upstream and downstream regions flanking the target gene to
be cloned into pGPI-SceI-XCm plasmid. The PCR amplifications
of these regions (about 500 bp each) were performed with the
Figure 1. The percentage surviving cells after treatment of B.
cenocepacia J2315 with tobramycin or ciprofloxacin. The results
from the biofilm experiments are indicated with open circles and those
from the planktonic cultures with triangles. Error bars represent min-
max (n $2).
doi:10.1371/journal.pone.0058943.g001
Table 4. The average percentage surviving cells for different Bcc strains after treatment of biofilms with high concentration of
tobramycin or ciprofloxacin (n $3).
Tobramycin (46MIC) Ciprofloxacin (46MIC)
Strain % surviving cells SD % surviving cells SD
B. cenocepacia J2315 0.3409 0.1877 10.2425 1.4721
B. cenocepacia K56-2 0.0064 0.0072 3.7081 3.5486
B. cenocepacia C5424 0.0319 0.0038 37.9861 15.6789
B. cenocepacia HI2424 0.0007 0.0007 3.6601 0.6902
B. ambifaria AMMD 0.0096 0.01424 14.6604 11.3466
B. lata ATCC 17769 0.8581 1.5047 4.6846 2.3581
B. multivorans ATCC17616 0.0011 0.0012 26.1484 21.8644
B. ubonensis LMG 20358 0.0548 0.0867 0.6486 1.1232
B. contaminans LMG 16227 0.0183 0.0268 10.5396 9.1080
B. dolosa LMG 18943 0.1165 0.0839 18.6143 6.3400
B. cepacia LMG 1222 0.2369 0.4611 4.3806 5.0242
B. vietnamiensis LMG 22486 0.8721 1.1513 1.8217 1.8081
B. pyrrocinia LMG 14191 2.4287 3.4043 6.7670 6.6825
doi:10.1371/journal.pone.0058943.t004
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HotStar HiFidelity polymerase kit (QIAGEN, Milan, Italy)
according to the manufacturer’s instructions. The following primer
pairs were used for the deletion of BCAL2118 (aceA): KOaceXL
(59-TTTCTAGAATTTCACGATACGGGA-39 XbaI site is un-
derlined), KOaceBL (59-TTGGATCCCGGACAGGTA-
GATGGC-39 BamHI site is underlined), KOaceBR (59-
TTGGATCCACAAGGGCTTCACGGC-39 BamHI site is un-
derlined), and KOaceKR (59-TTGGTACCCTATCTCGGCAT-
CATC-39 KpnI site is underlined). The following primer pairs were
used for the deletion of BCAM1588: KO1588XL (59-TTTCTA-
GATGACCGATCCGCACGC-39 XbaI site is underlined),
KO1588BL (59-TTGGATCCCGACCGACAACCTGGC-39
BamHI site is underlined), KO1588BR (59-
TTGGATCCCTTGTTCTGGGCACGC-39 BamHI site is un-
derlined), and KO1588KR (59-TTGGTACCATCAAA-
GAATTGTCC-39 KpnI site is underlined). The mutagenesis
plasmids were conjugated into B. cenocepacia J2315 and also into
the DBCAL2118 mutant strain, in order to create the
DBCAL2118DBCAM1588 double mutant (designated as D2).
Exconjugants were selected in the presence of Tp (200 mg/ml),
chloramphenicol (400 mg/ml)and ampicillin (200 mg/ml). The
insertion of the mutagenesis plasmid into B. cenocepacia genome
was confirmed by spraying catechol on the cells, which turn yellow
in the presence of this compound and 2,3-catechol-dioxygenase,
encoded by xylE (located in pGPI-SceI-XCm plasmid). Subse-
quently, pDAI-SceI-SacB plasmid (encoding the I-SceI endonucle-
ase), was mobilized by conjugation. Site-specific double-strand
breaks take place in the chromosome at the I-SceI recognition site,
which is present in pGPI-SceI-XCm plasmid, resulting in
tetracycline-resistant (due to the presence of pDAI-SceI-SacB) and
Tp-susceptible (indicating the loss of the integrated plasmid)
exconjugants. The gene deletions were confirmed by PCR
reaction and sequencing of the amplification products. The
isolation of deletion mutants cured from pDAI-SceI-SacB was
achieved by growing B. cenocepacia cells on LB medium without
antibiotics and then screening the resulting colonies for loss of
tetracycline resistance.
Construction of SDH Antisense Overexpression Mutants
To confirm the importance of SDH we constructed an antisense
overexpression mutant. Succinate dehydrogenase contains 4
subunits. Gene encoding for the two hydrophobic subunits sdhC
and sdhD (BCAM0967 and BCAM0968) were amplified by PCR
using a PhusionR high Fidelity PCR Kit (Bioke´ NEB, Leiden, the
Nederlands). The following primers were used for amplifying
BCAM0967: forward primer GTACAAGCATATGTTA-
GAATGCTCCGAACA (NdeI restriction site is underlined) and
reverse primer ATTCTAGAATGACTGACGCAGTAA-
GAAAGC (XbaI restriction site is underlined). The following
primers were used for amplifying BCAM0968: forward primer
GTACAAGCATATGTTACACTCTCCAGAGAA (NdeI restric-
tion site is underlined) and reverse primer AATCTAGAATGG-
CAGCCAACAACCGAATC (XbaI restrictions site is underlined).
Cycling conditions were 30s 98uC, 30 cycli of 10s 98uC, 30s 60uC,
and 24s 72uC, and 10 min 72uC. PCR products were purified with
a High Pure PCR product purification kit (Roche, Vilvoorde,
Belgium), digested and subsequently ligated into a plasmid
described by Cardona et al. [23], with a rhamnose-inducible
promotor and a Tp selection marker. DNA ligations, restriction
endonuclease digestions, and agarose gel electrophoresis were
performed according to standard techniques [24]. Restriction
enzymes and T4 DNA ligase were purchased from Bioke´ NEB.
Plasmid transformation experiments with E. coli DH5a were
carried out by the calcium chloride method [25]. Resistant
colonies were isolated and screened for the presence of the
construct. Plasmids were transferred into B. cenocepacia by
triparental mating [26] using pRK2013 as a helper plasmid
[27]. Exconjugants were selected on LB agar plates supplemented
with 800 mg/ml Tp and 50 mg/ml gentamicin.
Results and Discussion
Presence of Persister Cells
The presence of persister cells has been proposed as an
important factor in biofilm resilience [8]. To investigate the
presence of these dormant, multidrug-tolerant phenotypic variants
in Bcc biofilms, mature biofilms were treated with tobramycin, an
aminoglycoside antibiotic, frequently used in the treatment of
Figure 2. The number of cells in function of the DCHFDA-derived fluorescent signal for untreated and treated biofilms. Treated
biofilms were exposed to tobramycin in a concentration of 46MIC (1024 mg/ml) (24 h). The mean percentage of cells with a high fluorescent signal
(.30) is indicated (n = 7). Differences between treated and untreated biofilms are statistically significant (p,0.05).
doi:10.1371/journal.pone.0058943.g002
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Table 5. Differences in gene expression expressed as fold changes in treated vs untreated biofilms.
Gene number Annotation Microarray qPCR
Glyoxylate shunt
BCAL2122 Malate synthase 1.4* 23.3*
BCAL2118 Isocitrate lyase AceA 2.3* 1.9
BCAM1588 Isocitrate lyase 3.1* 1.6
BCAL0813 RNA polymerase factor sigma 54 21.5* 2
BCAL1949 Glyoxylate carboligase 21.5 2
Tricarboxylic acid cycle
BCAM0961 Aconitate hydratase 21.1 2
BCAM2701 Aconitate hydratase 21.3* 21.3
BCAM1833 Aconitate hydratase/methylisocitrate dehydratase 1.5* 1.1
BCAL2735 Isocitrate dehydrogenase 1.3* 22.5*
BCAL2736 Isocitrate dehydrogenase 1.4 1.5
BCAL1515 a-ketoglutarate dehydrogenase E1 22.0* 2
BCAL1516 Dihydrolipoamide succinyltransferase 23.3* 2
BCAL1517 Dihydrolipoamide dehydrogenase 22.5* 2
BCAL2207 Putative dihydrolipoamide dehydrogenase 21.3* 2
BCAL1215 Dihydrolipoamide dehydrogenase 21.4* 2
BCAL0956 Succinyl-CoA synthetase beta chain 22.0* 2
BCAL0957 Succinyl-CoA synthetase subunit alpha 23.3* 210.0*
BCAM0967 Putative succinate dehydrogenase 21.7* 2
BCAM0968 Putative succinate dehydrogenase 22.5* 2
BCAM0969 Succinate dehydrogenase flavoprotein 22.5* 2
BCAM0970 Succinate dehydrogenase iron-sulfur subunit 25.0* 225.0*
BCAL2908 Fumarate hydratase 21.3* 1.9*
BCAL2287 Putative fumarate dehydrogenase 1.0 2
BCAM0965 Malate dehydrogenase 1.0 22.0*
BCAL2746 Putative citrate synthase 21.3 2
BCAM0964 Putative lyase 21.4* 2
BCAS0023 HpcH/HpaI aldolase/citrate lyase family 22.5* 2
BCAM0972 Type II citrate synthase 25.0* 2
Oxidative phosphorylation
BCAL2142 Cytochrome o ubiquinol oxidase subunit III 22.0* 2
BCAL2143 Ubiquinol oxidase polypeptide I 22.0* 2
BCAL0750 Cytochrome c oxidase polypeptide I 21.7* 2
BCAL0752 Cytochrome c oxidase assembly protein 22.5* 2
BCAL0753 Hypothetical protein 22.5* 2
BCAL0754 Putative cytochrome c oxidase subunit III 22.0* 2
BCAL0030–0037 F0F1 ATP synthase subunit A-e 21.7*–22.5*u 2
BCAL2331–2343 NADH dehydrogenase subunit B-N 22.5–210.0*u 2
NAD(P)H production
BCAL3276 NAD-kinase 1.4* 2
BCAL0672 Isocitrate dehydrogenase kinase/phosphatase 1.3* 2
BCAL3359 Glutamate dehydrogenase 4.2* 2
BCAL3395 Malic enzyme 1.7* 2
Response to oxidative stress
BCAL1250 Putative glutathione S-transferase 1.6* 2
BCAL3331 Putative glutathione S-transferase 3.4* 2
BCAL0463 Putative thioredoxin 1.6* 2
BCAL2013 AhpC/TSA family protein 1.9* 2
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infected CF patients. The experiments were carried out using B.
cenocepacia J2315, a member of the epidemic ET12 lineage of which
the genome has been sequenced. The MIC was previously
determined to be 256 mg/ml [18]. Biofilms were treated with
various concentrations of tobramycin, ranging from 0.5 to
646MIC for 24 h.
We found that most cells were killed when J2315 biofilms were
treated with tobramycin in concentrations ranging from 1 to
46MIC, but even at higher concentrations (up to 646MIC), some
of the cells survived, indicating the presence of persisters (Fig. 1).
Similar results were obtained for other Bcc strains (Table 4).
Treatment with ciprofloxacin, a fluoroquinolone, resulted in an
even higher fraction of surviving cells (Fig. 1). The presence of
persisters is not unique to biofilms as we found similarly-shaped
survival curves in planktonic cultures, although the fraction of
surviving cells was considerably lower (Fig. 1).
Mulcahy et al. [28] analyzed clonal pairs of early and late P.
aeruginosa isolates from single CF patients and found that in the
majority of these patients, cultures of late isolates contained
increased numbers of drug-tolerant persister cells. We analyzed
clonal pairs of early and late Bcc isolates, obtained from 14 CF
patients. The MICs and the fraction of persister cells are shown in
Table 2. In general, the MICs were very similar (i.e. within a two-
fold dilution), indicating that the strains did not acquire resistance
during the course of the infection. Only in four patients the
persister fraction was higher in the late isolates. In three patients
there was no difference between the early and the late isolates and
in eight patients the number of surviving cells was lower in the late
than in the early isolate. Our observations suggest that, unlike in P.
aeruginosa, the fraction of persisters does not increase with the
duration of colonisation.
Figure 3. Effect of knocking out catalase function on survival of
peristers. The number of surviving cells in biofilms formed by B.
cenocepacia C5424 and two catalase mutants after treatment with
tobramycin in a concentration of 46MIC (512 mg/ml). Error bars
represent standard deviation (n = 3).
doi:10.1371/journal.pone.0058943.g003
Figure 4. Effect of superoxide dismutase inhibition on survival
of persisters. The number of surviving cells in B. cenocepacia J2315
biofilms after treatment with tobramycin alone (46MIC, 24 h) or in
combination with diethyldithiocarbamate (DETC 0.05 mM). Error bars
represent standard deviation (n = 3, p,0.05).
doi:10.1371/journal.pone.0058943.g004
Table 5. Cont.
Gene number Annotation Microarray qPCR
BCAL2106 Glutathion peroxidase 1.6* 2
BCAM2318 Putative ferredoxin oxidoreductase 210.0* 233.3*
Fe-storage
BCAM2627 Putative hemin ABC transporter protein 5.2* 2
BCAM2630 Hemin importer ATP binding subunit 2.8* 2
BCAM2224 Putative pyochelin receptor protein FptA 2.7* 2
BCAL1790 Putative iron-transport protein 2.5* 2
BCAL1347 Putative Fe uptake system extracellular binding protein 2.5* 2
BCAM2228 Putative pyochelin synthetase PchF 2.1* 2
BCAL1789 Putative iron-transport protein 2.0* 2
BCAL1371 Putative TonB-dependent siderophore receptor 2.0* 2
BCAL1702 Putative ornibactin biosynthesis protein 22.2* 2
-: no qPCR experiments were performed. *: significant change in expression between the treated and the untreated biofilms (n = 3, p,0.05). u: range of fold changes for
the various subunits.
doi:10.1371/journal.pone.0058943.t005
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Induction of ROS by Tobramycin
Recently, it was shown that bactericidal antibiotics induce the
production of reactive oxygen species (ROS) [13]. Tobramycin is
known to corrupt protein synthesis and by using ROS-specific
staining and flow cytometry, we confirmed that tobramycin also
drastically increased ROS production in treated sessile cells. Most
of the cells in treated, unlike untreated biofilms showed a high
fluorescent signal (Fig. 2).
Gene Expression in Cells Treated with High Doses of
Tobramycin
A transcriptome analysis showed a considerable change in gene
expression in sessile cells treated with high doses of tobramycin
relative to untreated sessile cells. Of the 8729 B. cenocepacia J2315
sequences represented on the array, 2688 (30.8%) were signifi-
cantly (p,0.05) upregulated, while the expression of 2413
sequences (27.6%) was significantly (p,0.05) downregulated. 669
(9.4%) protein-coding genes were significantly (p,0.05) upregu-
Figure 5. Effect of isocitrate lyase inhibition on B. cenocepacia J2315. The number of surviving cells in B. cenocepacia J2315 biofilms after
treatment with tobramycin (46MIC, 24 h) or ciprofloxacin (46MIC, 24 h) for biofilms grown in LB or LB supplemented with 50 mM itaconate (ita) or
10 mM 3-nitropropionate (3-NP). Error bars represent standard deviation. Statistically significant differences are indicated by an asterix (p,0.05,
n $3).
doi:10.1371/journal.pone.0058943.g005
Figure 6. Effect of iocitrate lyase inhibition on different Bcc strains. The number of surviving cells in different Bcc biofilms after treatment
with tobramycin (46MIC, 24 h) for biofilms grown in LB or LB supplemented with 50 mM itaconate. Statistically significant differences are indicated
by an asterix (p,0.05) (n$3).
doi:10.1371/journal.pone.0058943.g006
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lated by a factor of at least two, while the expression of 651
protein-coding genes (9.1%) was significantly (p,0.05) downreg-
ulated by a factor of at least two. In addition, a significant
differential expression of two or more was noted for 270 intergenic
regions (161 upregulated and 109 downregulated) and for
37 rRNA genes (all downregulated). Only a single tRNA gene
was upregulated, but 31 tRNA genes were downregulated. A
breakdown of differentially expressed protein-encoding genes by
functional category is presented in supplementary data (Fig. S2)
[29,30].
In this study we focused on genes involved in the production of
ROS and we found that the major pathways were all downreg-
ulated in cells surviving high doses of tobramycin treatment
(Table 5). We observed that genes from the TCA cycle, including
the majority of genes resulting in the production of NADH or
FADH2, genes involved in the electron transport chain and the
gene coding for ferredoxin reductase were downregulated in
persister cells. On the other hand genes involved in production of
NADPH, which plays a pivotal role in maintaining the proper
cellular redox balance, were upregulated [31]. For example
BCAL3276, the gene coding for NAD-kinase, an enzyme that
mediates the formation of NADP (a key coenzym known to tilt
cellular metabolism towards the synthesis of NADPH and away
from the formation of NADH) was upregulated. Similarly,
BCAL3395, the gene coding for malic enzyme, which is one of
the NADPH producing enzymes, was also upregulated. Isocitrate
dehydrogenase kinase-phosphatase, a bifunctional enzyme that
can inactivate isocitrate dehydrogenase, thereby directing isocit-
rate to the glyoxylate shunt, as well as both isocitrate lyase (ICL)
encodig genes were also found to be upregulated. In line with these
findings, BCAL0813, encoding a RNA polymerase factor sigma 54
which represses the glyoxylate pathway [32] was downregulated.
Glutamate dehydrogenase (BCAL3359) was upregulated and a-
ketoglutarate dehydrogenase (BCAL1515) was downregulated
indicating an increased production of a-ketoglutarate, a ROS
scavenger. Other proteins involved in response to oxidative stress
which were significantly upregulated include proteins involved in
glutathione biosynthesis, thioredoxine, peroxiredoxine and gluta-
thione peroxidase. The expression levels of selected genes were
confirmed by qPCR (Table 5).
Eradication of Persister Cells
Our transcriptome analysis suggested that protection against
ROS is important in survival of persister cells. To confirm this we
determined the number of persisters in biofilms formed by catalase
mutants. B. cenocepacia contains two catalases of which one (KatA)
is a specialized catalase/peroxidase which helps maintaining the
normal activity of the TCA cycle, while KatB is a classical
catalase/peroxidase which plays a global role in cellular protection
against oxidative stress by converting toxic H2O2 into H2O and
O2 [20]. We found the persister fraction to be slightly reduced in
biofilms formed by the DkatAmutant but almost 40-fold reduced in
biofilms formed by the DkatB mutant (Fig. 3). Furthermore, the
number of surviving cells was almost 100 times lower after
addition of the superoxide dismutase inhibitor diethyldithiocarba-
mate (DETC) (Fig. 4). Superoxide dismutases are antioxidant
enzymes that detoxify O2
2. by a dismutation reaction generating
H2O2 and O2 [16]. The inhibitor had no effect on untreated
biofilms in the concentrations tested, but reduced the number of
surviving cells in a concentration dependent manner when
combined with tobramycin. Together, these results indicate that
protection against ROS is indeed important for the survival of
persister cells.
Persister cells are typically considered as ‘‘dormant’’ (i.e.
metabolically inactive) cells [11] but our data challenge that
paradigm. While it is true that some pathways (i.e. TCA cycle)
were found to be downregulated, other pathways were upregu-
lated, and these may be a novel therapeutic target for combination
therapy. The importance of the upregulation of the glyoxylate
shunt for the survival of persister cells was confirmed by inhibition
Figure 7. A. The number of surviving cells in a double ICL mutant (D2) compared to wild type (WT). The number of surviving cells in a
double ICL mutant (D2) and in a wild type B. cenocepacia J2315 (WT) biofilm after treatment with tobramycin (4 MIC, 24h) for biofilms grown in LB or
LB supplemented with 10 mM 3-NP. Error bars represent standard deviation (n $3). For both strains, treatment with 3-NP resulted in significantly
(p,0.05) less surviving cells compared to the untreated control. B. Effect of succinate dehydrogenase inhibition on B. cenocepacia D2. The number of
surviving cells in B. cenocepacia D2 biofilms after treatment with tobramycin (46MIC, 24 h) for biofilms grown in LB or LB supplemented with 250 nM
2-thenoyltrifluoroacetone (Then). Error bars represent standard deviation (n = 4). Statistically significant differences are indicated by an asterix
(p,0.05).
doi:10.1371/journal.pone.0058943.g007
Mechanisms of Tolerance in Bcc Persisters
PLOS ONE | www.plosone.org 10 March 2013 | Volume 8 | Issue 3 | e58943
of ICL, the first enzyme in the shunt. Because persisters are
thought to be pre-existent, biofilms were grown in the presence of
these inhibitors. During treatment the inhibitors were removed
because of pH incompatibility with the antibiotics used. Pre-
treatment of B. cenocepacia biofilms with the ICL inhibitor itaconate
in a concentration of 50 mM reduced the persister fraction
approximately 10 fold when the biofilms were subsequently
treated with tobramycin. Pre-treatment with 10 mM 3-NP, a
more potent ICL inhibitor resulted in similar reductions (Fig. 5).
The concentrations of the ICL inhibitor used were below the MIC
and they did not affect growth in the untreated biofilms. In
addition, we did not observe an effect of either inhibitor on ROS
production (data not shown). The additional killing observed after
combined treatment with tobramycin and an ICL inhibitor was
not observed with ciprofloxacin (Fig. 5). This may suggest that this
effect is related to the type of antibiotic and/or the magnitude of
its effect on biofilms. However, this remains to be investigated.
Similar results were obtained in other Bcc bacteria (Fig. 6).
To confirm the results obtained by chemically inhibiting ICL,
we constructed a B. cenocepacia J2315 mutant in which both ICL
genes were inactivated. Surprisingly, there was no significant
decrease in the number of surviving cells after treatment with
tobramycin in the D2 mutant compared to wild type (Fig. 7A), but
we did find an additional effect after adding 3-NP to the mutant.
Itaconate and 3-NP are succinate analogues and besides inhibiting
ICL, they also inhibit succinate dehydrogenase (SDH) [33].
We hypothesised that an upregulation of ICL in persisters not
only limits the production of NADH (and thus limits ROS
production) but also leads to an increased intracellular succinate
concentration. Succinate can be oxidised by SDH, thereby
generating FADH2 which can lead to basal production of ATP
in persister cells in which other energy-generating systems are
downregulated. Itaconate and 3-NP likely kill persisters by shutting
down the remaining ATP production by inhibiting both ICL and
SDH. To test this hypothesis we constructed a SDH antisense
overexpression mutant in the D2 background, in which SDH is
inactivated if rhamnose is present. However, we noticed that Tp
(required to maintain the plasmid) and/or rhamnose (required to
induce antisense RNA expression) had a mild influence of biofilm
formation as such, and on the number of persisters in biofilms
(data not shown), which made interpretation of these data
impossible. However, addition of an ubiquinone type SDH
inhibitor, 2-thenoyltrifluoroacetone, to B. cenocepacia D2 biofilms
significantly (p,0.05) reduced the number of surviving persisters
(Fig. 7B), while not affecting the MIC for tobramycin (data not
shown).
The reaction catalysed by ICL also leads to the production of
glyoxylate. In B. cenocepacia glyoxylate can be used to form malate
(through the activity of malate synthase) or tartronate semialde-
hyde (through the activity of glyoxylate carboligase). There are two
malate synthases of which only one (BCAL2122) was slightly
upregulated and glyoxylate carboligase (BCAL1949) was slightly
downregulated (Table 5).
Conclusion
Our results contribute to a better understanding of the
molecular mechanisms responsible for the antimicrobial tolerance
of Bcc biofilms by demonstrating that these biofilms contain
tolerant persister cells. In these surviving persister cells, the TCA
cycle was downregulated and the expression of genes involved in
the electron transport chain was also downregulated. This way the
cells avoid the production of ROS. At the same time, persister cells
activate an alternative pathway, i.e. the glyoxylate shunt. When
biofilms were grown in the presence of an inhibitor of ICL and
SDH, less persisters survived. Similar results were obtained in
different species, indicating that this mechanism is widespread
within the Bcc. So far, most anti-persister strategies focussed on
‘‘reawaking’’ persisters for efficient killing [34], but we found that
inhibiting a cellular target can also reduce the number of surviving
persisters. This finding may provide novel approaches for
treatment of persister-related infections.
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Figure S1 Average expression stability values (M) of
remaining control genes during stepwise exclusion of
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used for normalization.
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Figure S2 Differentially expressed protein-coding genes
ordered by functional category.
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